112 Followers on Owler
OverviewCompetitorsFundingNews & Insights

Receptos Competitors or Alternatives

Receptos's top competitors include InteKrin, Physiogenex and Adimab.

Unlock 7 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Receptos's company profile

CEO

- -
25 - 100
$97.8M
$5M - 25M
  • $97.8M
    $5M - 25M
  • 25 - 100
    $97.8M
  • $5M - 25M
  • - -
  • 25 - 100
  • $97.8M
  • $5M - 25M
View ProfileView
1
Receptos's Competitor - InteKrin logo

Linda Higgins

President & CEO

69/100
25 - 100
$46.7M
$5M - 25M
  • $46.7M
    $5M - 25M
  • 25 - 100
    $46.7M
  • $5M - 25M
  • 69/100
  • 25 - 100
  • $46.7M
  • $5M - 25M
View ProfileView
2
Receptos's Competitor - Physiogenex logo

Thierry Sulpice

Founder

68/100
25 - 100
- -
$5M - 25M
  • - -
    $5M - 25M
  • 25 - 100
    - -
  • $5M - 25M
  • 68/100
  • 25 - 100
  • - -
  • $5M - 25M
View ProfileView
3
Receptos's Competitor - Adimab logo

Philip T. Chase

CEO

82/100
100 - 250
$32.3M
$5M - 25M
  • $32.3M
    $5M - 25M
  • 100 - 250
    $32.3M
  • $5M - 25M
  • 82/100
  • 100 - 250
  • $32.3M
  • $5M - 25M
View ProfileView
4
Receptos's Competitor - Biogen logo

Christopher A. Viehbacher

President & CEO

48/100
8,720
$250M
$9.7B
  • $250M
    $9.7B
  • 8,720
    $250M
  • $9.7B
  • 48/100
  • 8,720
  • $250M
  • $9.7B
View ProfileView
5
Receptos's Competitor - Sanofi Genzyme logo

CEO

- -
1,000 - 5,000
$34.1M
$1B - 5B
  • $34.1M
    $1B - 5B
  • 1,000 - 5,000
    $34.1M
  • $1B - 5B
  • - -
  • 1,000 - 5,000
  • $34.1M
  • $1B - 5B
View ProfileView
The top 10 competitors in Receptos' competitive set are InteKrin, Physiogenex, Adimab, Flexion, Biogen, Sanofi Genzyme, EMD Serono, TEVA, Novartis and Aegerion Pharmaceuticals. Together they have raised over 14.5B between their estimated 128.4K employees. Receptos's revenue is the ranked 10th among it's top 10 competitors. The top 10 competitors average 7.2B. Receptos has 68 employees and is ranked 10th among it's top 10 competitors. The top 10 competitors average 11,681.

Receptos VS InteKrin

InteKrin is seen as one of Receptos's top competitors. InteKrin was founded in Redwood City, California} in 06/2005. InteKrin is in the Biotechnology industry. Compared to Receptos, InteKrin generates $9.8M more revenue.

Receptos VS Physiogenex

Physiogenex is Receptos's #2 competitor. Physiogenex was founded in 06/2003, and its headquarters is in Labège, Other. Physiogenex competes in the Biotechnology industry. Physiogenex has 38 fewer employees than Receptos.

Receptos VS Adimab

Adimab is Receptos's #3 rival. Adimab is headquartered in Lebanon, New Hampshire, and was founded in 2007. Like Receptos, Adimab also competes in the Pharmaceuticals & Biotechnology industry. Adimab generates 254% the revenue of Receptos.

Looking for similar companies to Receptos?

Similar Companies

Pharmaceuticals companies in San Diego

See 222 companies 
Biotechnology companies in San Diego

See 553 companies 
Pharmaceuticals companies in San Diego County

See 280 companies 
Biotechnology companies in San Diego County

See 687 companies 
Pharmaceuticals & Biotechnology companies in San Diego

See 720 companies 
Pharmaceuticals & Biotechnology companies in San Diego County

See 904 companies 
Pharmaceuticals companies in California

See 1,457 companies 
Pharmaceuticals companies with revenue in $5.0-25M range

See 2,473 companies 
Pharmaceuticals companies with employees in 25-100 range

See 2,871 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for Receptos and Receptos's Competitors

April 1, 2025PMLiVE
The authorisation approximately triples the number of patients eligible to receive the therapy...
March 31, 2025centralcharts
Regulatory News: Medincell (Paris:MEDCL): More than 92% of schizophrenia patients taking Olanzapine LAI in the Phase 3 SOLARIS survey were satisfied or...
March 31, 2025Clinical Trials Arena
The Phase II study found that lepodisiran significantly reduced levels of genetically inherited cardiovascular risk factor. The post Eli Lilly's lepodi...
Today 10:03 AMPharmabiz
Pfizer Inc. announced that the European Commission (EC) has issued a decision amending the marketing authorization for Abrysvo, the company's bivalent ...
March 31, 2025GlobalNewswire
- Data Further Advance Understanding of VASCEPA®/VAZKEPA® Potential Mechanism of Action and Utility as A Complementary Therapy for Residual Risk Reduct...
April 1, 2025Korea Biomedical Review
Novartis has scored a win in Korea's reimbursement system, clearing its immunosuppressant Cosentyx (secukinumab) for use in children and teens with chr...
April 1, 2025Endpoints News
Eli Lilly's RNA candidate has reduced levels of a protein linked with cardiovascular disease risk in a mid-stage trial in patients with high cholestero...
April 1, 2025Marketscreener
Flagship Pioneering, announced an agreement between Pioneering Medicines, Flagship's in-house drug discovery and development unit, and Pfizer, to disco...
March 31, 2025Benzinga
Palatin's study shows co-administering bremelanotide with tirzepatide led to greater weight loss than tirzepatide alone, with further analysis ongoing....
April 1, 2025Openpr
The Latest study titled Topical Drug Delivery Market 2025, published by Coherent Market Insights, provides valuable insights into both regional and glo...

Frequently Asked Questions about Receptos

  1. Who are Receptos's top competitors?

    Receptos's top 3 competitors are InteKrin, Physiogenex, Adimab.

  2. Who is similar to Receptos?

    InteKrin is the most similar to Receptos. Physiogenex and Adimab are also similar to Receptos.

  1. Are Receptos and InteKrin competitors?

    Yes, InteKrin is one of Receptos’s top competitors.